Home > Chemicals & Materials > Specialty Chemicals > Custom Synthesis > Avidin Market

Avidin Market Share

  • Report ID: GMI6092
  • Published Date: Jun 2023
  • Report Format: PDF

Avidin Market Share

Some of the major market players operating in the avidin market are

  • Vector Laboratories
  • Thermo Fisher Scientific
  • Merck KGaA (Sigma-Aldrich)
  • Aviva Systems Biology
  • BioVectra
  • Cell Signaling Technology
  • Avidity

These players focus on strategic partnerships and new product launches & commercialization for market expansion. Furthermore, they heavily invest in research to introduce innovative products and garner maximum revenue in the market.

Authors: Kiran Pulidindi, Kunal Ahuja

Frequently Asked Questions (FAQ) :

The market size off avidin was valued at USD 220 million in 2022 and will reach USD 350 million by 2032, attributed to advancements in various biotechnological applications as well as the rising need for precise & efficient research tools.

The streptavidin segment accounted for a market value of around USD 150 million in 2022, owing to its strong binding affinity for biotin, which forms the basis of the biotin-streptavidin system.

U.S. dominated North America avidin market with a revenue of USD 62.7 million in 2022 and will expand at a significant pace from 2023 – 2032, attributed to the demand for reliable & accurate diagnostic solutions from the highly advanced diagnostic & healthcare industry in the region.

Vector Laboratories, Thermo Fisher Scientific, Merck KGaA (Sigma-Aldrich), Aviva Systems Biology, BioVectra, Cell Signaling Technology, and Avidity.

Avidin Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 5
  • Tables & Figures: 166
  • Countries covered: 21
  • Pages: 150
 Download Free Sample